Thomas G. McGinn, MD, MPH System Executive Vice President, CommonSpirit Health
On Tuesday, April 13, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) jointly announced a recommendation to pause administration of the Janssen/Johnson & Johnson (J&J) vaccine as it undergoes further investigation for rare blood clotting events.
Publish date:
Tuesday, May 25, 2021As part of our mission to improve the lives and wellbeing of those who we serve, CommonSpirit Health is committed to addressing violence.
Read More Additional information about CommonSpirit Supports 'Hospitals Against Violence' InitiativeThrough two new partnereships, CommonSpirit hospitals will host small cohorts of seminary students for six-week sessions.
Read More Additional information about Two CommonSpirit hospitals launching chaplain shadowing program for seminariansCommonSpirit Health has teamed up with Siemens Healthineers to acquire Block Imaging, a Michigan-based supplier of imaging parts and services.
Read More Additional information about CommonSpirit joins with Siemens to acquire radiology vendor